Search research articles
Contact Us
Filters
Showing results (1-10 of 118) with videos related to
Page
of 12
Sort By:
Clinical Neuropharmacology
|
May 19, 2011
Letter regarding "Treatment effects of gabapentin for primary insomnia"
Robert M Hamer, Pippa M Simpson
The American Journal of Psychiatry
|
June 3, 2009
Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials
Robert M Hamer, Pippa M Simpson
Pediatrics
|
July 4, 2007
Stressing about posttraumatic stress disorder
R Grant Steen, Robert M Hamer
JAMA
|
October 8, 2014
Antipsychotic medications for schizophrenia--reply
T Scott Stroup, Joseph P McEvoy, Robert M Hamer
International Clinical Psychopharmacology
|
May 31, 2012
Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable
Erica J Duncan, Sandra L Woolson, Robert M Hamer
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 27, 2005
Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis
R Grant Steen, Robert M Hamer, Jeffrey A Lieberman
Eating Behaviors
|
June 6, 2012
Plasma, salivary, and urinary oxytocin in anorexia nervosa: a pilot study
Elizabeth R Hoffman, Kimberly A Brownley, Robert M Hamer, et al.
Nature Reviews. Drug Discovery
|
March 7, 2006
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
T Scott Stroup, Wayne M Alves, Robert M Hamer, et al.
The Journal of Clinical Psychiatry
|
August 8, 2006
Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
Kate X Zhong, Dennis E Sweitzer, Robert M Hamer, et al.
International Clinical Psychopharmacology
|
June 5, 2009
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population
Erica J Duncan, Sandra L Woolson, Robert M Hamer, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 118) with videos related to
Sort By:
Page
of 12
Clinical Neuropharmacology
|
May 19, 2011
Letter regarding "Treatment effects of gabapentin for primary insomnia"
Robert M Hamer, Pippa M Simpson
The American Journal of Psychiatry
|
June 3, 2009
Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials
Robert M Hamer, Pippa M Simpson
Pediatrics
|
July 4, 2007
Stressing about posttraumatic stress disorder
R Grant Steen, Robert M Hamer
JAMA
|
October 8, 2014
Antipsychotic medications for schizophrenia--reply
T Scott Stroup, Joseph P McEvoy, Robert M Hamer
International Clinical Psychopharmacology
|
May 31, 2012
Treatment compliance in veterans administration schizophrenia spectrum patients treated with risperidone long-acting injectable
Erica J Duncan, Sandra L Woolson, Robert M Hamer
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
August 27, 2005
Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis
R Grant Steen, Robert M Hamer, Jeffrey A Lieberman
Eating Behaviors
|
June 6, 2012
Plasma, salivary, and urinary oxytocin in anorexia nervosa: a pilot study
Elizabeth R Hoffman, Kimberly A Brownley, Robert M Hamer, et al.
Nature Reviews. Drug Discovery
|
March 7, 2006
Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations
T Scott Stroup, Wayne M Alves, Robert M Hamer, et al.
The Journal of Clinical Psychiatry
|
August 8, 2006
Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study
Kate X Zhong, Dennis E Sweitzer, Robert M Hamer, et al.
International Clinical Psychopharmacology
|
June 5, 2009
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a Veterans Affairs population
Erica J Duncan, Sandra L Woolson, Robert M Hamer, et al.
Page
of 12